Sanofi Diversifies In China With $70 Million To Expand Production Capability For Animal Health Division Merial
This article was originally published in PharmAsia News
Executive SummarySHANGHAI - Sanofi-Aventis' animal health division Merial Animal Health broke ground on a $70 million expansion of its Nanchang manufacturing site, six months after Sanofi CEO Chris Viehbacher said his company aims to diversify in China
You may also be interested in...
A draft proposal by the Ministry of Agriculture comes at a time when several Big Pharma are pursuing opportunities in China’s veterinary market.